行情

ENZ

ENZ

Enzo Biochem
NYSE

实时行情|Nasdaq Last Sale

2.590
+0.040
+1.57%
盘后: 2.590 0 0.00% 16:00 01/24 EST
开盘
2.550
昨收
2.550
最高
2.654
最低
2.545
成交量
11.69万
成交额
--
52周最高
4.460
52周最低
2.400
市值
1.23亿
市盈率(TTM)
160.87
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ENZ 新闻

  • All Three Proxy Advisory Firms Recommend Shareholders Vote FOR Change to the Board of Enzo Biochem on the Blue Card
  • Business Wire.4天前
  • Enzo Biochem Comments on ISS Report
  • Business Wire.01/17 20:02
  • Harbert Discovery Fund Issues Press Release Highlighting Glass Lewis Has Recommended Vote for Election Of Firm Nominees To Enzo Biochem Board
  • Benzinga.01/16 18:12
  • Glass Lewis Recommends Shareholders Vote For the Election of Both Harbert Discovery Fund Nominees to Enzo Biochems Board
  • Business Wire.01/16 18:03

更多

所属板块

医疗设施与服务
-1.65%
医疗保健提供商与服务
-2.08%

热门股票

名称
价格
涨跌幅

ENZ 简况

Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. It offers a menu of molecular and other clinical laboratory tests or procedures. Enzo Life Sciences manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers. Enzo Therapeutics is a biopharmaceutical venture that develops multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. Its products in the development pipeline include a range of assays for detection of various women's health infectious agents, as well as for use in the identification of pathogens for other markets.
展开

Webull提供Enzo Biochem, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。